These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 8920796)
1. Expression of p53 and apoptosis of tumor cells in locally advanced cervical carcinoma after cisplatin based neoadjuvant chemotherapy. Garzetti GG; Ciavattini A; Provinciali M; Di Stefano G; Lucarini G; Goteri G; Biagini G Anticancer Res; 1996; 16(5B):3229-34. PubMed ID: 8920796 [TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix. Serur E; Mathews RP; Gates J; Levine P; Maiman M; Remy JC Gynecol Oncol; 1997 May; 65(2):348-56. PubMed ID: 9159350 [TBL] [Abstract][Full Text] [Related]
3. Modulation of expression of p53 and cell proliferation in locally advanced cervical carcinoma after neoadjuvant combination chemotherapy. Garzetti GG; Ciavattini A; Lucarini G; Goteri G; De Nictolis M; Romanini C; Biagini G Eur J Obstet Gynecol Reprod Biol; 1995 Nov; 63(1):31-6. PubMed ID: 8674562 [TBL] [Abstract][Full Text] [Related]
4. [Evaluation of neoadjuvant chemotherapy for locally advanced cervical cancinoma]. Cheng XD; Lü WG; Ye F; Chen HZ; Xie X Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):95-8. PubMed ID: 16640856 [TBL] [Abstract][Full Text] [Related]
5. Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report. Fuso L; Mazzola S; Marocco F; Ferrero A; Dompè D; Carus AP; Zola P Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S187-91. PubMed ID: 16185756 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of cyclooxygenase-2 protein and its relationship to apoptosis in cervical carcinoma treated with neoadjuvant chemotherapy. Nagai N; Tian X; Mukai K; Hirata E; Kusuda T; Shiroyama Y; Shigemasa K; Ohama K Int J Mol Med; 2003 Nov; 12(5):709-14. PubMed ID: 14532998 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza. Zanetta G; Fei F; Mangioni C Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040 [TBL] [Abstract][Full Text] [Related]
8. Decrease in tumor volume and histologic response to intraarterial neoadjuvant chemotherapy in patients with cervical and endometrial adenocarcinoma. Fujiwaki R; Takahashi K; Kitao M Gynecol Oncol; 1997 May; 65(2):258-64. PubMed ID: 9159335 [TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant intraarterial infusion chemotherapy in patients with stage IB2-IIIB cervical cancer. Yamakawa Y; Fujimura M; Hidaka T; Hori S; Saito S Gynecol Oncol; 2000 May; 77(2):264-70. PubMed ID: 10785476 [TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer. Sugiyama T; Nishida T; Hasuo Y; Fujiyoshi K; Yakushiji M Gynecol Oncol; 1998 May; 69(2):130-6. PubMed ID: 9600820 [TBL] [Abstract][Full Text] [Related]
11. Influence of neoadjuvant polychemotherapy on natural killer cell activity in patients with locally advanced cervical squamous carcinoma. Garzetti GG; Ciavattini A; Provinciali M; Valensise H; Romanini C; Fabris N Gynecol Oncol; 1994 Jan; 52(1):39-43. PubMed ID: 7508412 [TBL] [Abstract][Full Text] [Related]
12. p53 and bcl-2 expression in locally advanced squamous cell head-neck cancer treated with platinum based chemotherapy and radiotherapy. Giatromanolaki A; Koukourakis M; Zaramboukas T; Skordalaki A; Arapantoni P; Georgoulias V; Fountzilas G Anticancer Res; 1998; 18(6B):4685-92. PubMed ID: 9891541 [TBL] [Abstract][Full Text] [Related]
13. Assessment of apoptosis in oesophageal carcinoma preoperatively treated by chemotherapy and radiotherapy. Moreira LF; Naomoto Y; Hamada M; Kamikawa Y; Orita K Anticancer Res; 1995; 15(2):639-44. PubMed ID: 7539243 [TBL] [Abstract][Full Text] [Related]
15. [Neoadjuvant chemotherapy before radiotherapy in treatment of patients with cervical carcinoma]. Li QS; Zhang XQ; Li DP; Sheng XG; Du XL; Song QQ Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):83-7. PubMed ID: 16640853 [TBL] [Abstract][Full Text] [Related]
16. Expression of p53 gene in stage IIIA non-small cell lung cancer in patients after neoadjuvant chemotherapy with Vepesid and Cisplatin. Mańdziuk S; Dudzisz-Sledź M; Korszeń-Pilecka I; Milanowski J; Wojcierowski J; Korobowicz E Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):154-7. PubMed ID: 15314976 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer. Shiga H; Heath EI; Rasmussen AA; Trock B; Johnston PG; Forastiere AA; Langmacher M; Baylor A; Lee M; Cullen KJ Clin Cancer Res; 1999 Dec; 5(12):4097-104. PubMed ID: 10632346 [TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy. Lai CH; Hsueh S; Chang TC; Tseng CJ; Huang KG; Chou HH; Chen SM; Chang MF; Shum HC Gynecol Oncol; 1997 Mar; 64(3):456-62. PubMed ID: 9062150 [TBL] [Abstract][Full Text] [Related]
20. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix. Tabata T; Takeshima N; Nishida H; Hirai Y; Hasumi K Anticancer Res; 2003; 23(3C):2885-90. PubMed ID: 12926129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]